DK0635132T4 - Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener - Google Patents

Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener

Info

Publication number
DK0635132T4
DK0635132T4 DK93907460T DK93907460T DK0635132T4 DK 0635132 T4 DK0635132 T4 DK 0635132T4 DK 93907460 T DK93907460 T DK 93907460T DK 93907460 T DK93907460 T DK 93907460T DK 0635132 T4 DK0635132 T4 DK 0635132T4
Authority
DK
Denmark
Prior art keywords
react
broadly reactive
opsonic antibodies
staphylococcal antigens
reactive opsonic
Prior art date
Application number
DK93907460T
Other languages
English (en)
Other versions
DK0635132T3 (da
Inventor
Gerald W Fischer
Original Assignee
Jackson H M Found Military Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26709752&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0635132(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jackson H M Found Military Med filed Critical Jackson H M Found Military Med
Publication of DK0635132T3 publication Critical patent/DK0635132T3/da
Application granted granted Critical
Publication of DK0635132T4 publication Critical patent/DK0635132T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK93907460T 1992-03-19 1993-03-18 Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener DK0635132T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85402792A 1992-03-19 1992-03-19
US3347693A 1993-03-18 1993-03-18
PCT/US1993/002275 WO1993019373A1 (en) 1992-03-19 1993-03-18 Broadly reactive opsonic antibodies that react with common staphylococcal antigens

Publications (2)

Publication Number Publication Date
DK0635132T3 DK0635132T3 (da) 2001-02-26
DK0635132T4 true DK0635132T4 (da) 2008-08-25

Family

ID=26709752

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93907460T DK0635132T4 (da) 1992-03-19 1993-03-18 Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener

Country Status (12)

Country Link
EP (3) EP1033135A1 (da)
JP (3) JP4124816B2 (da)
AT (1) ATE197506T1 (da)
AU (1) AU3805893A (da)
CA (1) CA2132421C (da)
DE (1) DE69329642T3 (da)
DK (1) DK0635132T4 (da)
ES (1) ES2155450T5 (da)
GR (1) GR3035155T3 (da)
IL (1) IL105119A (da)
PT (1) PT635132E (da)
WO (1) WO1993019373A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US7279162B1 (en) 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
US5955074A (en) * 1990-10-22 1999-09-21 Henry M. Jackson Foundation For The Advancement Of Military Medicine Directed human immune globulin for the prevention and treatment of staphylococcal infections
PT783520E (pt) * 1994-09-21 2002-05-31 Henry M Jackson Found Advanc M Anticorpos opsonicos amplamente reactivos que reagem com antigenios de estafilococos comuns
AU2006203322B2 (en) * 1997-06-16 2010-04-29 Altor Bioscience Corporation Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
CA2373221A1 (en) * 1999-05-03 2000-11-30 Yashwant M. Deo Human antibodies to staphylococcus aureus
US7723087B2 (en) 2002-11-12 2010-05-25 The Brigham And Women's Hospital, Inc. Nucleic acid molecules for enhanced production of a bacterial polysaccharide and methods of use thereof
US10919956B2 (en) 2002-11-12 2021-02-16 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
PL1745075T3 (pl) 2004-04-21 2013-09-30 Brigham & Womens Hospital Inc Peptydy wiążące poli-N-acetyloglukozaminę (PNAG/DPNAG) i sposoby ich zastosowania
WO2007001423A2 (en) * 2004-10-21 2007-01-04 Wyeth Immunogenic compositions of staphylococcus epidermidis polypeptide and polynucleotide antigens
ATE505535T1 (de) * 2005-08-23 2011-04-15 Iq Corp Verfahren zur herstellung stabiler b-lymphozyten
PL1821053T3 (pl) 2006-01-31 2016-04-29 Electrolux Home Products Corp Nv Urządzenie do szybkiego schładzania napojów i sposób jego kontrolowania
KR20110031393A (ko) 2008-07-21 2011-03-25 더 브리검 앤드 우먼즈 하스피털, 인크. 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
BRPI1015567A2 (pt) 2009-06-22 2021-08-31 Wyeth Llc Composições imunogênicas de antígenos de staphylococcus aureus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
WO1988004669A1 (en) * 1986-12-15 1988-06-30 Mitsui Toatsu Chemicals, Inc. Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
JPH08504167A (ja) * 1992-02-25 1996-05-07 アメリカ合衆国 スタフィロコーカス感染の予防及び処理のための指図されたヒト免疫グロブリン

Also Published As

Publication number Publication date
JPH07507387A (ja) 1995-08-10
EP0635132A1 (en) 1995-01-25
JP2007119468A (ja) 2007-05-17
CA2132421C (en) 2010-11-23
DE69329642T2 (de) 2001-03-15
CA2132421A1 (en) 1993-09-20
AU3805893A (en) 1993-10-21
DK0635132T3 (da) 2001-02-26
IL105119A (en) 1999-06-20
DE69329642T3 (de) 2009-05-20
DE69329642D1 (de) 2000-12-14
JP2002255998A (ja) 2002-09-11
EP1033135A1 (en) 2000-09-06
ATE197506T1 (de) 2000-11-11
WO1993019373A1 (en) 1993-09-30
JP4171596B2 (ja) 2008-10-22
ES2155450T3 (es) 2001-05-16
GR3035155T3 (en) 2001-04-30
JP4353974B2 (ja) 2009-10-28
IL105119A0 (en) 1993-08-18
EP1027896A1 (en) 2000-08-16
PT635132E (pt) 2001-03-30
EP0635132B1 (en) 2000-11-08
EP0635132B2 (en) 2008-05-14
ES2155450T5 (es) 2008-11-01
JP4124816B2 (ja) 2008-07-23

Similar Documents

Publication Publication Date Title
DK0635132T3 (da) Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener
WO1998057994A3 (en) Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
McCabe et al. Immunization with rough mutants of Salmonella minnesota: protective activity of IgM and IgG antibody to the R595 (Re chemotype) mutant
JP4656728B2 (ja) ブドウ球菌抗原及びワクチン
Spika et al. Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome
ATE302411T1 (de) Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens
FR2746398B1 (fr) Anticorps specifique de staphylococcus aureaus, et utilisations
ATE425251T1 (de) Impfstoffe welche antiidiotypische antikörper enthalten, die kohlenhydrate von streptococcus gruppe b nachahmen
Cryz Jr et al. Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine
CA2145397A1 (en) Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
DK0476226T3 (da) Monoklonalt antistof mod humant IgE
ATE398137T1 (de) Porphyromonas gingivalis antigene zur diagnose und behandlung von periodontitis
DK0783520T3 (da) Bredt reaktive opsoniske antistoffer, som er reaktive mod fælles stafylokok-antigener
Valentin-Weigand et al. Role of α2-macroglobulin in phagocytosis of group A and C streptococci
KR880001815A (ko) 슈도모나스 에루기노사 편모에 대한 단일클론항체
ATE111745T1 (de) Antikörper gegen streptococcus.
CA2297694A1 (en) Antibodies and diagnostic methods for the diagnosis of pestviruses
EP0450573A3 (en) Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections
Genco et al. Purification, characterization, and immunogenicity of cell-associated glucan from Streptococcus mutans
EP0368466A3 (en) Compositions and methods for the treatment and prevention of gram-negative bacterial infections
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
FI894048A (fi) Menetelmä Pseudomonas aeruginosa-infektioita vastaan vaikuttavien valmisteiden sekä immunoglobuliini-G-pitoisten, Pseudomonas aeruginosa-bakteeria vastaan vaikuttavien valmisteiden tuottamiseksi
Bruderer et al. The Use of Antibody Specificity and Affinity in Determining the Protectiveness of Human Monoclonal Antibodies Against Fatal Infections with Nosocomial Gram-Negative Bacteria
ATE204761T1 (de) Pharmazeutische antigen-/antikörperpräparation